Controlled clinical trial evaluating safety and efficacy of Vascular Electrical Stimulation Therapy on severe dysmenorrhea.

Controlled randomized Phase II clinical trial evaluating safety and efficacy of Vascular Electrical Stimulation Therapy on severe dysmenorrhea

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR201909636228452

Enrollment

100

Registered

2019-09-12

Start date

2019-09-30

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea

Interventions

VEST Treatment

Placebo group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Severe menstrual pain (VAS over 4) Dysmenorrhea every month for at least one year

Exclusion criteria

Exclusion criteria: Patients treated with analgesic drug prior to recrutment Patient under 18 years old Chronic renal disease Cardiac insuffisiency Suspicion of general or vaginal infection Gastric ulcere Chronical pelvic pain Pacemaker NSAIDs allergy or intolerance

Design outcomes

Primary

Measure	Time frame
Pain Duration	—

Secondary

Measure	Time frame
NSAIDs consumption	—

Countries

Cote Divoire

Contacts

Public ContactEtienne L Hermite

Coordinator

elhermite@diavein.com+33615773953

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026